University Of Zurich
Clinical trials sponsored by University Of Zurich, explained in plain language.
-
New hope for patients with rare brain lining cancer spread
Disease control OngoingThis early-phase study tests a new way to give immunotherapy drugs (nivolumab and ipilimumab) for patients with lung cancer or melanoma that has spread to the lining of the brain and spinal cord (leptomeningeal metastases). The drugs are given both directly into the spinal fluid …
Phase: PHASE1 • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 16, 2026 12:49 UTC
-
Heart study seeks best order for two common procedures
Disease control OngoingThis study looks at nearly 1,000 people with severe aortic stenosis (a narrowed heart valve) and blocked heart arteries. It compares doing artery stenting before versus after valve replacement to see which order is safer and more effective. The goal is to reduce death, heart atta…
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
New therapy mimics baby movements to boost brain development in preterm infants
Disease control OngoingThis study tests a therapy for very preterm babies (born before 32 weeks) who show abnormal movements. The therapy involves gently guiding the baby's movements to mimic normal patterns, with parents trained to continue at home. Researchers will compare motor development at 3 mont…
Phase: NA • Sponsor: University of Zurich • Aim: Disease control
Last updated Jun 12, 2026 12:04 UTC
-
Robotic lung biopsy: a sharper tool for spotting cancer?
Diagnosis OngoingThis study compares a new technique that combines cone-beam CT scans with a robotic bronchoscope against standard methods for taking lung tissue samples. The goal is to see if the new approach can diagnose lung cancer and other lung diseases more accurately. About 300 adults who …
Phase: NA • Sponsor: University of Zurich • Aim: Diagnosis
Last updated Jun 05, 2026 12:05 UTC
-
New cream may soothe painful rashes from cancer drugs
Symptom relief OngoingThis study tests whether a cream containing ruxolitinib can improve skin rashes caused by anti-PD1 cancer immunotherapy. About 22 adults with this type of rash will use the cream for 12 weeks. The goal is to see if the rash clears by at least 90%.
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Symptom relief
Last updated Jun 15, 2026 19:04 UTC
-
MRI-Guided radiation trial aims to sharper target pelvic tumors
Knowledge-focused OngoingThis study tests whether a new method of radiation therapy, which uses an MRI scan to plan treatment and a CT scan to deliver it, is feasible for treating pelvic lymph node metastases. Twenty adults with confirmed cancer spread to pelvic lymph nodes will receive stereotactic body…
Phase: NA • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:02 UTC
-
New study tracks prostate tumors on MRI after radiation
Knowledge-focused OngoingThis study aims to see how prostate tumors change on MRI scans shortly after a precise type of radiation therapy (SBRT). Researchers will compare these MRI changes with PSA levels in the blood. The study involves 28 men with localized prostate cancer and is designed to improve un…
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC
-
Endometriosis MRI study pulled before it even started
Knowledge-focused TerminatedThis study was designed to see if newer MRI techniques could improve how doctors find and assess endometriosis. It planned to compare MRI results with ultrasound and surgery. However, the study was withdrawn before any participants were enrolled, so no results are available.
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 01, 2026 17:53 UTC